CCIA
PPH icon

Cherry Creek Investment Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cherry Creek Investment Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$491K Sell
4,481
-785
-15% -$87.5K 0.19% 76
2026
Q2 		$576K Sell
5,266
-8,558
-62% -$886K 0.23% 68
2026
Q1 		$1.44M Buy
13,824
+695
+5% +$74K 0.62% 36
2025
Q4 		$1.35M Buy
+13,129
New +$1.28M 0.58% 37

Other funds holding PPH

RBC
Rye Brook Capital Greenwich, Connecticut $154M AUM 17.54% 1-Year Est. Return
WWM
WT Wealth Management Scottsdale, Arizona $357M AUM 15.82% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $292M AUM 8.92% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $291M AUM 14.48% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
HI
Hudock Inc Williamsport, Pennsylvania $790M AUM 18.43% 1-Year Est. Return
IPAM
Investment Partners Asset Management Metuchen, New Jersey $186M AUM 19.73% 1-Year Est. Return
VIP
Value Investment Professionals New York $115M AUM 13% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $650M AUM 25.51% 1-Year Est. Return

Cherry Creek Investment Advisors's PPH Position: Q3 2026 in Review

Cherry Creek Investment Advisors reduced its VanEck Pharmaceutical ETF (PPH) stake by 15% in Q3 2026, selling an estimated $87.5K and leaving 4,481 shares worth $491K. The position accounts for 0.19% of the portfolio, ranked #76.

Cherry Creek Investment Advisors first reported a position in PPH in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.44M in Q1 2026. 17 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • Cherry Creek Investment Advisors held 4,481 shares of VanEck Pharmaceutical ETF worth $491K as of Q3 2026.
  • Cherry Creek Investment Advisors sold 785 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $87.5K.
  • VanEck Pharmaceutical ETF made up 0.19% of Cherry Creek Investment Advisors's portfolio in Q3 2026, its #76 holding.
  • Cherry Creek Investment Advisors first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and has held it in 4 quarters since.
  • Cherry Creek Investment Advisors's VanEck Pharmaceutical ETF position peaked at $1.44M in Q1 2026.
  • 17 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.